Biomarker response on exposure to sunitinib and its primary metabolite (SU12662) in metastatic colorectal cancer patients.

1. Juni 2011

Kanefendt, F., Lindauer, A., Kinzig, M., Strumberg, D., Scheulen, M.E., Mross, K., Fischer, R., Moritz, B., Sörgel, F., Jaehde, U., 2011.

Int J Clin Pharmacol Ther 49, 88–90.